FDA experts recommend new drug to reduce sensitivity to peanut allergens

A Food and Drug Administration (FDA) panel has on Friday recommended approval of the first-ever drug to treat life-threatening peanut allergies in children, a condition that confounds and frightens families across the country.
 
The recommendation all but assures the agency will approve the drug, called Palforzia and made by Aimmune Therapeutics. The FDA typically follows the advice of its expert advisory committees.
 
Some panel members expressed reservations about the safety of the drug, since patients receiving treatment experienced more allergic reactions than those given a placebo. There is also little long-term safety data about a treatment that may